Seer (SEER) Cash from Financing Activities (2020 - 2026)
Seer (SEER) posted quarterly Cash from Financing Activities of -$2.6 million for Q1 2026, down 73.64% year-over-year from -$9.9 million in Q1 2025, and down 1923.78% quarter-over-quarter from $143000.0 in Q4 2025.
Seer (SEER) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Seer's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$2.6 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 73.64% year-over-year to -$2.6 million; the TTM figure through Mar 2026 stood at -$11.7 million (up 10.18% YoY), while the FY2025 annual figure was -$10.6 million, up 8.06% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$2.6 million, down from $143000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $2.1 million in Q4 2022, with the low at -$7.2 million in Q2 2025.
- The 5-year median for Cash from Financing Activities is $29000.0 (2023), against an average of -$1.3 million.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities soared 310.71% in 2022, then plunged 23803.57% in 2024.
- Seer's Cash from Financing Activities stood at $2.1 million in 2022, then sank by 91.36% to $182000.0 in 2023, then slumped by 791.21% to -$1.3 million in 2024, then soared by 111.37% to $143000.0 in 2025, then tumbled by 1923.78% to -$2.6 million in 2026.
- Business Quant data shows SEER's Cash from Financing Activities at -$2.6 million in Q1 2026, $143000.0 in Q4 2025, and -$2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.42 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -6.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -207,909.22 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -273.15 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 36.24 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 27.18 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | -205,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -205,000.00 |
| Jun 30, 2026 | -205,000.00 |
| Mar 31, 2026 | -2.61 Mn |
| Mar 31, 2026 | -2.61 Mn |
| Dec 31, 2025 | 143,000.00 |
| Dec 31, 2025 | 143,000.00 |
| Sep 30, 2025 | -1.99 Mn |
| Sep 30, 2025 | -1.99 Mn |
| Jun 30, 2025 | -7.22 Mn |
| Jun 30, 2025 | -7.22 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Sep 30, 2024 | -6.64 Mn |
| Sep 30, 2024 | -6.64 Mn |
| Jun 30, 2024 | -3.60 Mn |
| Jun 30, 2024 | -3.60 Mn |
| Dec 31, 2023 | 182,000.00 |
| Dec 31, 2023 | 182,000.00 |